Metraipolis › archive › dc_faefc1432226

Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study — Europe PMC PMID:41568389

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41568389
DOI
10.3389/fonc.2025.1709974
License (as archived)
solo-consultazione
Archived
2026-11-07T01:02:21.225Z
SHA-256 of the archived text
45df248a329199bc313b13baa7d61cf4743a5923b16eda9cfe3bc8f79bd398c7
Stable URL of this page
https://metraipolis.com/documento/dc_faefc1432226

How to cite

Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study — Europe PMC PMID:41568389 — Europe PMC (en), https://europepmc.org/article/MED/41568389 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_faefc1432226 (Metraipolis archive dc_faefc1432226, sha256 45df248a329199bc313b13baa7d61cf4743a5923b16eda9cfe3bc8f79bd398c7)
BibTeX
@misc{dcfaefc1432226,
  title = {Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study — Europe PMC PMID:41568389},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41568389},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_faefc1432226; sha256 45df248a329199bc313b13baa7d61cf4743a5923b16eda9cfe3bc8f79bd398c7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41568389. Agents can read the archived copy with the MCP tool read_document.